VolitionRx Limited (VNRX)

ASE – Цена в реальном времени. Валюта: USD

0.64

-0.07 (-10.19%)

Рынок открыт: Aug 12, 2026, 1:14 PM EDT

0.70

-0.01 (-1.55%)

Предыдущая сессия: Aug 11, 2026, 7:54 PM EDT

12.08.2026

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Removes Centralized Lab Dependency for $3.8 Billion Global Addressable Market for NETosis Testing HENDERSON, Nev., Aug. 12, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that results utilizing its lateral flow prototype are highly correlated with results utilizing Volition's established automated Nu.Q® NETs test in critically ill sepsis patients1 , thereby expanding beyond centralized laboratory testing.

11.08.2026

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Conference call to take place on Friday, August 14 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.

05.08.2026

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization.

Видео

No Data

There is no data to display

VolitionRx Limited (VNRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

VolitionRx Limited (VNRX)

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Видео

No Data

Пресс-релизы

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Видео

No Data

Пресс-релизы

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Search stocks

VolitionRx Limited (VNRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

VolitionRx Limited (VNRX)

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Видео

No Data

Пресс-релизы

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology

Видео

No Data

Пресс-релизы

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology